Compared to the aggregate P/E ratio of 27.38 in the Pharmaceuticals industry, AstraZeneca Inc. has a higher P/E ratio of ...

GSK has a lower P/E than the aggregate P/E of 27.89 of the Pharmaceuticals industry. Ideally, one might believe that the ...

Investing.com -- Goldman Sachs downgraded Partners Group (SIX:PGHN) to “neutral” from “buy,” citing 2025 earnings risks and valuation concerns. Shares of the private equity firm was down 3 ...

KLA Corporation may not be a household name, but it's clearly moving the market's needle with some stylish momentum swagger. With a top-tier Momentum Style Score of A and a not-too-shabby VGM Score of ...

Shiba Inu's price has dropped 10% to $0.00001164 in one week. The long-short ratio in the perpetual futures market has fallen to 0.9298, indicating bearish sentiment among traders.

MU boasts an average earnings surprise of 10.7%. Moreover, analysts are expecting MU's earnings to grow 433.1% for the current fiscal year. Reveal Winning Stocks ...

McKesson Corporation (NYSE:MCK) is one of the 12 best healthcare stocks to buy now. On June 11, Morgan Stanley reiterated the stock’s ‘Overweight’ rating and increased the price target to ...

It has a forward price-to-earnings ratio of 20, a few points lower than the sector median of 22. Its forward EV-to-EBITDA ratio of 15 is also lower than other companies in the software industry.

Stitch Fix stock will be in the spotlight as it publishes its earnings. The company’s business has slowed in the past few years. Its earnings are expected to show that revenues continued falling.